Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Gm2 Gangliosidosis

Gm2 Gangliosidosis

📧 Sign up to get email alerts when something new happens for Gm2 Gangliosidosis.

Top drugs studied for this disease

Nizubaglustat (3)
Zavesca (miglustat) (1)
Pyrimethamine (Daraprim) (1)
N-Acetyl-L-Leucine (1)
AZ-3102 (1)
Pyrimethamine (1)
AXO-AAV-GM2 (1)
Zavesca (1)
Miglustat (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms